Argenx Se ARGX
NASDAQ ARGX
$962.22 +16.40 (+1.73%)
At close: Sep 24, 2026 · 4:00 PM EDT

Argenx Se (ARGX) Market Capitalization (2017 - 2026)

Argenx Se's (ARGX) quarterly Market Capitalization came in at $57.4 billion in Q2 2026, up 71.42% on a YoY basis from $33.5 billion in Q2 2025, and up 27.05% quarter-over-quarter from $45.2 billion in Q1 2026.

Analysis

Argenx Se (ARGX) Market Capitalization (2017 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Market Capitalization for 10 consecutive years, with $57.4 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Market Capitalization rose 71.42% year-over-year to $57.4 billion; the trailing twelve-month figure through Jun 2026 stood at $57.4 billion (up 71.42% YoY), and the FY2025 full-year result was $52.0 billion, up 39.27% from the prior year.
  • Market Capitalization grew to $57.4 billion in Q2 2026 per ARGX's latest filing, from $45.2 billion in the prior quarter.
  • Across five years, Market Capitalization topped out at $57.4 billion in Q2 2026 and bottomed at $16.3 billion in Q1 2022.
  • Historically, Market Capitalization has averaged $30.8 billion across 5 years, with a median of $26.3 billion in 2023.
  • The sharpest annual moves came in 2023 and 2026: Market Capitalization grew 7.31% in 2023, then jumped 71.42% in 2026.
  • Over 5 years, Market Capitalization stood at $21.0 billion in 2022, then increased by 7.31% to $22.5 billion in 2023, then jumped by 65.94% to $37.4 billion in 2024, then jumped by 39.27% to $52.0 billion in 2025, then advanced by 10.32% to $57.4 billion in 2026.
  • According to Business Quant data, Market Capitalization over the past three periods registered $57.4 billion, $45.2 billion, and $52.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Argenx Se 58.53 Bn 53.35 Bn 1.37 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 57.41 Bn
Mar 31, 2026 45.19 Bn
Dec 31, 2025 52.04 Bn
Sep 30, 2025 44.81 Bn
Jun 30, 2025 33.49 Bn
Mar 31, 2025 35.96 Bn
Dec 31, 2024 37.37 Bn
Sep 30, 2024 32.09 Bn
Jun 30, 2024 25.46 Bn
Mar 31, 2024 23.31 Bn
Dec 31, 2023 22.52 Bn
Sep 30, 2023 27.23 Bn
Jun 30, 2023 21.59 Bn
Mar 31, 2023 20.64 Bn
Dec 31, 2022 20.99 Bn
Sep 30, 2022 18.24 Bn
Jun 30, 2022 19.58 Bn
Mar 31, 2022 16.29 Bn
Dec 31, 2021 18.09 Bn
Sep 30, 2021 14.37 Bn
API Access

Argenx Se Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=ARGX&period=max&api_key=YOUR_API_KEY